SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.88-1.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (26743)12/3/1998 3:16:00 PM
From: celeryroot.com  Read Replies (1) of 32384
 
Mudcat, why do you keep saying the fda is giving Ligand a hard time?
What they are doing is following the precedures. In the case of Panetran, it was reviewed within 6 months. This is not the norm. It is usually 1 year. They are not giving Ligand hard time as you state. I suggest if you want to no what the FDA giving someone a hard time is all about go check Chir/Ceph on myotropin.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext